20MG
Peptide Source
Description
RETATRUTIDE 20MG is a high-purity peptide (≥99%, HPLC-verified) supplied as lyophilized powder, intended strictly for laboratory research. Investigated in preclinical studies for adiposity, insulin resistance, and energy balance regulation. Research evaluates fat loss, metabolic markers, and tolerability in animal models. Key effects investigated in research: rapid and profound weight loss; significant reduction of visceral fat; potent appetite suppression; reduces food cravings; optimizes metabolism and insulin sensitivity.
Mechanism of Action
This peptide acts as a selective agonist of GLP-1, GIP, and/or Glucagon receptors, modulating central and peripheral metabolic pathways. Activation of these receptors reduces appetite via hypothalamic signaling, delays gastric emptying, and increases lipid oxidation in adipose tissue, resulting in significant reduction of visceral fat and body weight in research models.
Specifications
Technical Specifications
(Retatrutide)
